نتایج جستجو برای: b interferon

تعداد نتایج: 954732  

2017
Li Zhang Yu-Tzu Tai Matthew Zhi Guang Ho Lugui Qiu Kenneth C. Anderson

B cell lymphoma and multiple myeloma (MM) are the most common hematological malignancies which benefit from therapeutic monoclonal antibodies (mAbs)-based immunotherapies. Despite significant improvement on patient outcome following the use of novel therapies for the past decades, curative treatment is unavailable for the majority of patients. For example, the 5-year survival of MM is currently...

Journal: :JPMA. The Journal of the Pakistan Medical Association 2016
Shafique Rehman Arain Tahira Perveen Umer

Pegylated interferon remains the first line treatment for patients with hepatitis D virus and more than one year therapy may be necessary. Interferon a has the most extensive clinical application and is used for the treatment of chronic hepatitis B and D virus as well as HCV infections. The attachment of polyethylene glycol to interferon increases its half-life. Treatment with peg interferon is...

Journal: :Antiviral research 2012
Xiaopan Wu Zhenhui Xin Xilin Zhu Liping Pan Zhuo Li Hui Li Ying Liu

Host genetic polymorphisms in interferon pathway genes are reported to be associated with response to interferon therapy. Five hundred and forty-eight α interferon treatment-naïve chronic hepatitis B patients were enrolled in the retrospective nested case-control study. All patients received α interferon based treatment and were examined for therapy efficacy. We genotyped 115 polymorphisms from...

Multiple sclerosis (MS) is an inflammatory disorder, in which neurons in central nervous system (CNS) become demyelinated .MS is named for its formation of plaques due to sclerosis of myelin. Variable degree of demyelination results in mild, mediate or severe symptomatic episodes of this disease. It is commonly characterized by recurrent relapses and often followed by severe neurological disabi...

Background: Interferon (IFN) are small proteins that belong to the cytokine family and may interfere with viral infections and some cancers. There are many studies focused on the PEGylated interferon’s bioactivity. In this study, we used solid lipid nanoparticles (SLNs) to produce new drug formulations, with the aim of reducing costs, increasing effectiveness, and also reducing side effects, an...

2018
Josefine Radke Randi Koll Corinna Preuße Debora Pehl Kremena Todorova Constanze Schönemann Yves Allenbach Eleonora Aronica Marianne de Visser Frank L. Heppner Joachim Weis Soroush Doostkam Thierry Maisonobe Olivier Benveniste Hans-Hilmar Goebel Werner Stenzel

Objective To study the B-cell content, organization, and existence of distinct B-cell subpopulations in relation to the expression of type 1 interferon signature related genes in dermatomyositis (DM). Methods Evaluation of skeletal muscle biopsies from patients with adult DM (aDM) and juvenile DM (jDM) by histology, immunohistochemistry, electron microscopy, and quantitative reverse-transcrip...

اخوندی میبدی, محسن, امیربیگی, محمدکاظم, سلمان روغنی, حسن, عزیزی, ریحانه,

Introduction: Based on data from recent trials, peginterferon and ribavirin combination therapy is the standard of care in treating patients with chronic HCV infection, but because of high costs, many patients may deprive from treatment. Methods: We conducted a clinical trial on HCV patients in Yazd in gastroenterology clinic. Thirty patients received conventional subcutaneous interferon alf...

Journal: :Journal of the Formosan Medical Association = Taiwan yi zhi 2001
J H Kao M Y Lai P J Chen Y M Cheng D S Chen

BACKGROUND AND PURPOSE For the retreatment of chronic hepatitis C patients relapsing after, or non-responsive to, previous interferon therapy, the efficacy of combination therapy with interferon alfa plus ribavirin is superior to interferon alone. The aim of this study was to determine whether prolonged interferon alfa treatment after 24-week combination therapy can further increase the efficac...

Journal: :Arteriosclerosis and thrombosis : a journal of vascular biology 1992
G Schectman S Kaul R A Mueller E C Borden A H Kissebah

Interferons have been shown to lower low density lipoprotein (LDL) cholesterol concentrations by 20-50%. To evaluate the effect of interferons on LDL metabolic behavior in individuals with normal and mildly elevated LDL cholesterol levels, autologous LDL labeled with 125I was administered to subjects at baseline and during interferon treatment. Interferon beta serine (IFN-beta serine) was admin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید